To Research Or Not Research – That Is The Question
I imagine we’ll be seeing a slew of articles like this over the next couple of months
Research on Cancer, chronic pain, nausea and more are grinding to a halt due to the federal funding freeze.
New research is validating cannabis can help cancer, chronic pain or more. It is a key alternative to avoid opioid use for post surgery pain. But now the deal funding freeze to hit medical marijuana research has significant implications for various sectors of scientific research, including medical marijuana studies. While the freeze has been temporarily halted, the uncertainty it created has already affected ongoing projects and future research prospects.
Medical marijuana research has long faced challenges due to federal restrictions. Despite growing interest in its therapeutic potential, the classification of marijuana as a Schedule I drug under the Controlled Substances Act limits research opportunities. Historically, most federal funding for cannabis research has focused on its potential harms rather than its medical benefits. The National Institutes of Health (NIH) and the National Institute on Drug Abuse (NIDA) are key players in controlling access to research-grade cannabis, which further complicates the process for researchers.
Read on
